Noninvasive Staging of Hepatic Fibrosis in Patients with Autoimmune Liver Disease Using Deep Learning
Authors:
- 12 February 2026
- journal article
- Published by Elsevier in Academic Radiology
- Vol. 33 (6) , 2403-2411
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A survey on the interpretability of deep learning in medical diagnosisMultimedia Systems, 2022
- Cellular and Molecular Mechanisms Underlying Liver Fibrosis RegressionCells, 2021
- Recent advances in clinical practice: epidemiology of autoimmune liver diseasesGut, 2021
- Liver Fibrosis: Mechanistic Concepts and Therapeutic PerspectivesCells, 2020
- Liver Fibrosis: Deep Convolutional Neural Network for Staging by Using Gadoxetic Acid–enhanced Hepatobiliary Phase MR ImagesRadiology, 2018
- Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’Journal of Hepatology, 2015
- Fibrosis — A Common Pathway to Organ Injury and FailureNew England Journal of Medicine, 2015
- Autoimmune liver disease, autoimmunity and liver transplantationJournal of Hepatology, 2014
- British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitisGut, 2011
- Practices of Liver Biopsy in France: Results of a Prospective Nationwide SurveyHepatology, 2000